NIKKEI 225
23,346.49-13.81(-0.06%)HANG SENG
23,742.51+25.66(+0.11%)CRUDE OIL
39.93+0.13(+0.33%)
Rite Aid Corporation (RAD)
| Previous close | 13.52 |
| Open | 13.75 |
| Bid | 13.77 x 1000 |
| Ask | 13.79 x 800 |
| Day's range | 13.51 - 14.08 |
| 52-week range | 6.59 - 23.88 |
| Volume | 2,911,975 |
| Avg. volume | 3,332,968 |
| Market cap | 769.315M |
| Beta (5Y monthly) | 0.76 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -7.80 |
| Earnings date | 24 Sep 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 14 Oct 1999 |
| 1y target est | 10.17 |
- Business Wire
Trent Kruse Named Senior Vice President of Investor Relations and Treasury at Rite Aid
Rite Aid (NYSE: RAD) has announced the appointment of Trent Kruse as senior vice president of investor relations and treasury as the business continues to chart a course toward a thriving future. Rite Aid has appointed a number of senior leaders in recent months to align key personnel with the company’s RxEvolution strategy, which puts the pharmacist at the center of a holistic approach to healthcare and builds a dominant mid-market pharmacy benefit management company.
- Zacks
Rite Aid (RAD) to Report Q2 Earnings: What's in the Offing?
Rite Aid's (RAD) Q2 results are likely to reflect gains from enhanced digital capabilities to provide essential services, sturdy Elixir performance and solid growth in prescription deliveries.
- Zacks
Earnings Preview: Rite Aid (RAD) Q2 Earnings Expected to Decline
Rite Aid (RAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
